Retirement Planning Company of New England’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,370
| Closed | -$297K | – | 231 |
|
|
2024
Q2 | $297K | Buy |
+10,370
| New | +$297K | 0.16% | 157 |
|
|
2024
Q1 | – | Sell |
-6,280
| Closed | -$212K | – | 231 |
|
|
2023
Q4 | $212K | Sell |
6,280
-310
| -5% | -$10.5K | 0.1% | 208 |
|
|
2023
Q3 | $202K | Buy |
6,590
+130
| +2% | +$3.99K | 0.11% | 191 |
|
|
2023
Q2 | $259K | Buy |
6,460
+230
| +4% | +$9.22K | 0.15% | 175 |
|
|
2023
Q1 | $254K | Buy |
6,230
+405
| +7% | +$16.5K | 0.15% | 174 |
|
|
2022
Q4 | $225K | Buy |
5,825
+370
| +7% | +$14.3K | 0.15% | 187 |
|
|
2022
Q3 | $290K | Buy |
+5,455
| New | +$290K | 0.21% | 148 |
|
|
2022
Q1 | – | Sell |
-100
| Closed | -$6K | – | 687 |
|
|
2021
Q4 | $6K | Buy |
+100
| New | +$6K | ﹤0.01% | 736 |
|